Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Phase II of Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer

NCT02591784 is registered in ClinicalTrials.gov with Biotech Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT02591784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02591784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Phase II of Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer
Lead sponsor
Biotech Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2008
Completion date
December 31, 2011
Enrollment
42 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal